KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Illumina (ILMN) Other Accumulated Expenses: 2011-2014

  • Illumina's Other Accumulated Expenses rose 30.20% to $24.6 million in Q4 2014 from the same period last year, while for Dec 2014 it was $24.6 million, marking a year-over-year increase of 30.20%. This contributed to the annual value of $24.6 million for FY2014, which is 30.20% up from last year.
  • According to the latest figures from Q4 2014, Illumina's Other Accumulated Expenses is $24.6 million, which was up 30.20% from $18.9 million recorded in Q4 2013.
  • In the past 5 years, Illumina's Other Accumulated Expenses ranged from a high of $24.6 million in Q4 2014 and a low of $9.5 million during Q1 2011.
  • Its 3-year average for Other Accumulated Expenses is $18.0 million, with a median of $18.9 million in 2013.
  • Data for Illumina's Other Accumulated Expenses shows a peak YoY skyrocketed of 30.20% (in 2014) over the last 5 years.
  • Quarterly analysis of 4 years shows Illumina's Other Accumulated Expenses stood at $9.5 million in 2011, then grew by 10.13% to $10.4 million in 2012, then reached $18.9 million in 2013, then skyrocketed by 30.20% to $24.6 million in 2014.
  • Its Other Accumulated Expenses stands at $24.6 million for Q4 2014, versus $18.9 million for Q4 2013 and $10.4 million for Q1 2012.